Get to know our clinical trials
Clinical trial of GEN1047 in subjects with malignant solid tumors.
RESEARCH TRIAL TO STUDY THE SAFETY OF GEN1047 IN SUBJECTS WITH MALIGNANT SOLID TUMORS
- FIRST HUMAN, OPEN-LABEL, DOSE-ESCALATION, STEP-UP CLINICAL TRIAL WITH EXPANSION COHORTS TO EVALUATE THE SAFETY OF GEN1047 IN SUBJECTS WITH MALIGNANT SOLID TUMORS
- Code EudraCT: 2021-001790-2
- Protocol number: GCT1047-01
- Promoter: Genmab A/S
- Link to Clinical Trials
* The trials only admit a limited number of patients and are subject to inclusion and exclusion criteria. The specialist who assesses your case will inform you of the conditions required to participate in the clinical trial.
Do you want to participate in this trial?
Request an appointment for our specialists to assess whether you qualify for this clinical trial
Do you prefer to send us your reports?
If you prefer, you can send us your medical information and our specialists will evaluate your case without the need to come to the Clinica.